The Russian government may allow parallel imports (imports of non-counterfeit product from another country without the permission of the intellectual property owner) of drugs to Russia, according to Andrey Kashevarov, Deputy Head of the Russian Federal Anti-Monopoly Service (FAS), reports The Pharma Letter’s Russia correspondent.
It is planned that the government may allow imports of drugs, registered in Russia, as well as imports of non-registered drugs from countries such as Germany, Switzerland, the USA, Japan and some others.These imports will be supplied through specialized customs offices with laboratories that will be able to check the quality of drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze